tiprankstipranks
Trending News
More News >
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market

Enanta Pharmaceuticals (ENTA) Ownership - Who Owns Enanta Pharmaceuticals?

Compare
175 Followers

Enanta Pharmaceuticals (ENTA) Ownership Overview

6.73%13.77%27.67%11.26%40.56%
27.67% Other Institutional Investors
11.26% ETFs
40.56% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 52.71% of the company’s stock is owned by Institutional Investors, 6.73% is owned by Insiders, and 40.56% is owned by Public Companies and Individual Investors.
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 41.45% of the company’s stock is owned by Institutional Investors, 6.73% is owned by Insiders, and 11.26% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 12, 2025
xxxxxxxxxxxxx
$256050
Dec 10, 2024
xxxxxxxxxxxxx
$18401
Dec 10, 2024
xxxxxxxxxxxxx
$18401
Dec 10, 2024
xxxxxxxxxxxxx
$6980

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,122,262Institution9.93%14,961,947
1,152,018Institution5.39%8,121,727
1,038,000Institution4.86%7,317,900
924,543Institution4.33%6,518,028
902,822Institution4.22%6,364,895
864,654Insider4.04%6,095,811
518,838Institution2.43%3,657,808
374,535Insider1.75%2,640,472
221,816Institution1.04%1,563,803
214,151Institution1.00%1,509,765

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
924,543Institution4.33%6,518,028
518,838Institution2.43%3,657,808
221,816Institution1.04%1,563,803
214,151Institution1.00%1,509,765
119,191Institution0.56%840,297
109,547Institution0.51%772,306
108,582Institution0.51%765,503
107,436Institution0.50%757,424
94,098Institution0.44%663,391
84,628Institution0.40%596,627

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
629,597Institution2.95%3,733,510
501,195Institution2.34%3,648,700
294,946Institution1.38%1,749,030
174,004Institution0.81%1,266,749
120,444Institution0.56%876,832
100,605Institution0.47%596,588
91,951Institution0.43%669,403
63,274Institution0.30%375,215
57,015Institution0.27%415,069
49,499Institution0.23%371,243

FAQ

Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 27.67% of the company's stock is held by institutional investors, 6.73% is held by insiders, and 40.56% is held by retail investors.
    What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 27.67% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
      What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.56% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
        Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
        Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis